Latest data on lecanemab to be presented at Alzheimer's Association International Conference (AAIC)

Corporate Breaking News

Home : Latest data on lecanemab to be presented at Alzheimer's Association International Conference (AAIC)

Jul 26 2022	Latest data on lecanemab to be presented at Alzheimer's Association International Conference (AAIC)
STOCKHOLM, July 26, 2022 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present new data for lecanemab (BAN2401), an investigational anti-amyloid beta (Aβ) protofibril antibody for the treatment of mild cognitive impairment (MCI) due to Alzheimer's...


Source:https://www.prnewswire.com:443/news-releases/latest-data-on-lecanemab-to-be-presented-at-alzheimers-association-international-conference-aaic-301593043.html

Related News
» Expanded Polystyrene Market Size for Packaging to Grow by USD 3.15 Bn, BASF SE, and Kaneka Corp. Among Key Vendors - Technavio » Brittney Griner's team to present evidence ahead of her testimony